⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for melanoma advanced

Every month we try and update this database with for melanoma advanced cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic MelanomaNCT05732805
Melanoma
Melanoma (Skin)
Melanoma Stage ...
Melanoma Stage ...
Melanoma Unrese...
Melanoma Metast...
Melanoma Advanc...
BCD-217
BCD-100
Placebo
18 Years - Biocad
A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic MelanomaNCT05732805
Melanoma
Melanoma (Skin)
Melanoma Stage ...
Melanoma Stage ...
Melanoma Unrese...
Melanoma Metast...
Melanoma Advanc...
BCD-217
BCD-100
Placebo
18 Years - Biocad
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: